lobbying_activities: 1259301

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1259301	194e8070-a66d-4986-9ee9-e5125367cb7a	Q2	TAKEDA PHARMACEUTICALS AMERICA, INC.	57954	TAKEDA PHARMACEUTICALS AMERICA INC	2012	second_quarter	HCR	health reform and the un/underinsured and implications of ACA SCOTUS decision; chronic disease legislation (diabetes, mental health, obesity, CKD); value based insurance design, quality of care, adhereance, ACA implementation; Anit-Gout USP matters; HR 5 IPAB repeal;	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE		290000	0	0	2012-07-09T15:30:21.733000-04:00